Allspring Global Investments Holdings LLC Buys 2,959 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Allspring Global Investments Holdings LLC increased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.8% during the 3rd quarter, Holdings Channel reports. The firm owned 390,147 shares of the healthcare conglomerate’s stock after acquiring an additional 2,959 shares during the period. Allspring Global Investments Holdings LLC’s holdings in UnitedHealth Group were worth $228,111,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of UNH. Kathleen S. Wright Associates Inc. bought a new stake in shares of UnitedHealth Group during the 3rd quarter valued at $27,000. Macroview Investment Management LLC raised its position in shares of UnitedHealth Group by 671.4% during the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock valued at $28,000 after purchasing an additional 47 shares during the period. Delos Wealth Advisors LLC raised its position in shares of UnitedHealth Group by 757.1% during the 1st quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock valued at $30,000 after purchasing an additional 53 shares during the period. Bbjs Financial Advisors LLC bought a new stake in UnitedHealth Group in the 2nd quarter valued at $31,000. Finally, Global Wealth Strategies & Associates increased its holdings in UnitedHealth Group by 152.4% in the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after acquiring an additional 32 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Price Performance

Shares of UNH stock opened at $569.61 on Monday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.88. The company has a market capitalization of $525.99 billion, a P/E ratio of 37.11, a P/E/G ratio of 1.67 and a beta of 0.58. The company’s 50-day simple moving average is $584.42 and its two-hundred day simple moving average is $534.68. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $608.63.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The firm had revenue of $100.82 billion during the quarter, compared to analysts’ expectations of $99.14 billion. During the same quarter in the prior year, the company earned $6.56 EPS. The company’s revenue was up 9.2% compared to the same quarter last year. As a group, equities analysts anticipate that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were given a $2.10 dividend. The ex-dividend date was Monday, September 16th. This represents a $8.40 annualized dividend and a dividend yield of 1.47%. UnitedHealth Group’s payout ratio is presently 54.72%.

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on the stock. UBS Group reduced their price target on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday, October 16th. Bank of America reduced their price target on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday, October 16th. Hsbc Global Res downgraded shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Thursday. StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Wednesday, October 16th. Finally, Jefferies Financial Group upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and boosted their target price for the stock from $481.00 to $647.00 in a report on Wednesday, July 17th. Three investment analysts have rated the stock with a hold rating, eighteen have issued a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, UnitedHealth Group has a consensus rating of “Moderate Buy” and an average target price of $615.58.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.